4-Hydroxy-2-nonenal-modified glyceraldehyde-3-phosphate dehydrogenase is degraded by cathepsin G

Free Radical Biology and Medicine

Volumn 43, Issue 12, 2007, Pages 1604-1615

  Tsuchiya, Yukihiro ^a   Okuno, Yasutaka ^a   Hishinuma, Kayoko ^a   Ezaki, Asami ^a   Okada, Go ^a   Yamaguchi, Mitsune ^a   Chikuma, Toshiyuki ^a   Hojo, Hiroshi ^a  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

4 Hydroxy 2 nonenal; Cathepsin G; Glyceraldehyde 3 phosphate dehydrogenase; HNE modified protein; Oxidative stress; U937 cell

Indexed keywords

4 HYDROXYNONENAL; CATHEPSIN G; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROTEIN P27; PROTEIN P28;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PURIFICATION; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; RNA INTERFERENCE;

ALDEHYDES; AMINO ACID CHLOROMETHYL KETONES; CATHEPSINS; FREE RADICALS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; OXIDATION-REDUCTION; PEPTIDE MAPPING; RNA INTERFERENCE; RNA, SMALL INTERFERING; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; U937 CELLS;

EID: 36249018862     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.08.024     Document Type: Article

References (79)

1. Marnett L.J., Riggins J.N., and West J.D. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J. Clin. Invest. 111 (2003) 583-593
2. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog. Lipid Res. 42 (2003) 318-343
3. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr. 57 (1993) 779S-785S (discussion 785S-786S)
4. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991) 81-128
5. Poli G., and Schaur R.J. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50 (2000) 315-321
6. Nakashima I., Liu W., Akhand A.A., Takeda K., Kawamoto Y., Kato M., and Suzuki H. 4-Hydroxynonenal triggers multistep signal transduction cascades for suppression of cellular functions. Mol. Aspects Med. 24 (2003) 231-238
7. Dianzani M.U. 4-Hydroxynonenal from pathology to physiology. Mol. Aspects Med. 24 (2003) 263-272
8. Parola M., Bellomo G., Robino G., Barrera G., and Dianzani M.U. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid. Redox Signal. 1 (1999) 255-284
9. Rosenfeld M.E., Palinski W., Yla-Herttuala S., Butler S., and Witztum J.L. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 10 (1990) 336-349
10. Ando Y., Brannstrom T., Uchida K., Nyhlin N., Nasman B., Suhr O., Yamashita T., Olsson T., EI-Salhy M., and Uchino M. Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid. J. Neurol. Sci. 156 (1998) 172-176
11. Calingasan N.Y., Uchida K., and Gibson G.E. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J. Neurochem. 72 (1999) 751-756
12. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., and Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA 93 (1996) 2696-2701
13. Shibata N., Nagai R., Uchida K., Horiuchi S., Yamada S., Hirano A., Kawaguchi M., Yamamoto T., Sasaki S., and Kobayashi M. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res. 917 (2001) 97-104
14. Okamoto K., Toyokuni S., Uchida K., Ogawa O., Takenewa J., Kakehi Y., Kinoshita H., Hattori-Nakakuki Y., Hiai H., and Yoshida O. Formation of 8-hydroxy-2′-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int. J. Cancer 58 (1994) 825-829
15. Lucas D.T., and Szweda L.I. Cardiac reperfusion injury: aging, lipid peroxidation, and mitochondrial dysfunction. Proc. Natl. Acad. Sci. USA 95 (1998) 510-514
16. Uchida K., and Stadtman E.R. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction. J. Biol. Chem. 268 (1993) 6388-6393
17. Ishii T., Tatsuda E., Kumazawa S., Nakayama T., and Uchida K. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase. Biochemistry 42 (2003) 3474-3480
18. Szweda L.I., Uchida K., Tsai L., and Stadtman E.R. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Selective modification of an active-site lysine. J. Biol. Chem. 268 (1993) 3342-3347
19. Mitchell A.E., Morin D., Lame M.W., and Jones A.D. Purification, mass spectrometric characterization, and covalent modification of murine glutathione S-transferases. Chem. Res. Toxicol. 8 (1995) 1054-1062
20. Vander Jagt D.L., Hunsaker L.A., Vander Jagt T.J., Gomez M.S., Gonzales D.M., Deck L.M., and Royer R.E. Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem. Pharmacol. 25 (1997) 1133-1140
21. Davis D.W., Hamilton Jr. R.F., and Holian A. 4-Hydroxynonenal inhibits interleukin-1 beta converting enzyme. J. Interferon Cytokine Res. 17 (1997) 205-210
22. Del Corso A., Dal Monte M., Vilardo P.G., Cecconi I., Moschini R., Banditelli S., Cappiello M., Tsai L., and Mura U. Site-specific inactivation of aldose reductase by 4-hydroxynonenal. Arch. Biochem. Biophys. 350 (1998) 245-248
23. Bulteau A.L., Lundberg K.C., Humphries K.M., Sadek H.A., Szweda P.A., Friguet B., and Szweda L.I. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J. Biol. Chem. 276 (2001) 30057-30063
24. Okada K., Wangpoengtrakul C., Osawa T., Toyokuni S., Tanaka K., and Uchida K. 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J. Biol. Chem. 274 (1999) 23787-23793
25. Liu W., Akhand A.A., Kato M., Yokoyama I., Miyata T., Kurokawa K., Uchida K., and Nakashima I. 4-Hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J. Cell Sci. 112 (1999) 2409-2417
26. Taylor A., and Davies K.J. Protein oxidation and loss of protease activity may lead to cataract formation in the aged lens. Free Radic. Biol. Med. 3 (1987) 371-377
27. Agarwal S., and Sohal R.S. Aging and proteolysis of oxidized proteins. Arch. Biochem. Biophys. 309 (1994) 24-28
28. Grune T., and Davies T.J. Breakdown of oxidized proteins as a part of secondary antioxidant defenses in mammalian cells. Biofactors 6 (1997) 165-172
29. Grune T., and Davies K.J. The proteasomal system and HNE-modified proteins. Mol. Aspects Med. 24 (2003) 195-204
30. Davies K.J. Degradation of oxidized proteins by the 20S proteasome. Biochimie 83 (2001) 301-310
31. Marques C., Pereira P., Taylor A., Liang J.N., Reddy V.N., Szweda L.I., and Shang F. Ubiquitin-dependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells. FASEB J. 18 (2004) 1424-1426
32. Tsuchiya Y., Yamaguchi M., Chikuma T., and Hojo H. Degradation of glyceraldehyde-3-phosphate dehydrogenase triggered by 4-hydroxy-2-nonenal and 4-hydroxy-2-hexenal. Arch. Biochem. Biophys. 438 (2005) 217-222
33. Sirover M.A. Emerging new functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. Life Sci. 58 (1996) 2271-2277
34. Sirover M.A. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim. Biophys. Acta 1432 (1999) 159-184
35. Chuang D.M., Hough C., and Senatorov V.V. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 269-290
36. Glaser P.E., and Gross R.W. Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehyde-3-phosphate dehydrogenase: discrimination between glycolytic and fusogenic roles of individual isoforms. Biochemistry 34 (1995) 12193-12203
37. Launay J.F., Jellali A., and Vanier M.T. Glyceraldehyde-3-phosphate dehydrogenase is a microtubule binding protein in a human colon tumor cell line. Biochim. Biophys. Acta 996 (1989) 103-109
38. Meyer-Siegler K., Mauro D.J., Seal G., Wurzer J., deRiel J.K., and Sirover M.A. A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. USA 88 (1991) 8460-8464
39. Singh R., and Green M.R. Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science 259 (1993) 365-368
40. Grosse F., Nasheuer H.P., Scholtissek S., and Schomburg U. Lactate dehydrogenase and glyceraldehyde-phosphate dehydrogenase are single-stranded DNA-binding proteins that affect the DNA-polymerase-alpha-primase complex. Eur. J. Biochem. 160 (1986) 459-467
41. Morgenegg G., Winkler G.C., Hubscher U., Heizmann C.W., Mous J., and Kuenzle C.C. Glyceraldehyde-3-phosphate dehydrogenase is a nonhistone protein and a possible activator of transcription in neurons. J. Neurochem. 47 (1986) 54-62
42. Hara M.R., Cascio M.B., and Sawa A. GAPDH as a sensor of NO stress. Biochim. Biophys. Acta 1762 (2006) 502-509
43. Sawa A., Khan A.A., Hester L.D., and Snyder S.H. Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc. Natl. Acad. Sci. USA 94 (1997) 11669-11674
44. Saunders P.A., Chalecka-Franaszek E., and Chuang D.M. Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. J. Neurochem. 69 (1997) 1820-1828
45. Ishitani R., Tanaka M., Sunaga K., Katsube N., and Chuang D.M. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol. Pharmacol. 35 (1998) 701-707
46. Kragten E., Lalande I., Zimmermann K., Roggo S., Schindler P., Muller D., van Oostrum J., Waldmeier P., and Furst P. Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl. J. Biol. Chem. 273 (1998) 5821-5828
47. Carlile G.W., Chalmers-Redman R.M., Tatton N.A., Pong A., Borden K.E., and Tatton W.G. Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. Mol. Pharmacol. 57 (2000) 2-12
48. Dastoor Z., and Dreyer J.L. Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. J. Cell Sci. 114 (2001) 1643-1653
49. Hara M.R., Agrawal N., Kim S.F., Cascio M.B., Fujimuro M., Ozeki Y., Takahashi M., Cheah J.H., Tankou S.K., Hester L.D., Ferris C.D., Hayward S.D., Snyder S.H., and Sawa A. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat. Cell Biol. 7 (2005) 665-674
50. Yamaguchi M., Tsuchiya Y., Hishinuma K., Chikuma T., and Hojo H. Conformational change of glyceraldehyde-3-phosphate dehydrogenase induced by acetylleucine chloromethyl ketone is followed by unique enzymatic degradation. Biol. Pharm. Bull. 26 (2003) 1648-1651
51. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
52. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
53. Laemmli U.K., and Favre M. Maturation of the head of bacteriophage T4: I. DNA packaging events. J. Mol. Biol. 80 (1973) 575-599
54. Hansen M.B., Nielsen S.E., and Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119 (1989) 203-210
55. Salvesen G., Farley D., Shuman J., Przybyla A., Reilly C., and Travis J. Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinases. Biochemistry 26 (1987) 2289-2293
56. Watorek W., van Halbeek H., and Travis J. The isoforms of human neutrophil elastase and cathepsin G differ in their carbohydrate side chain structures. Biol. Chem. Hoppe Seyler 376 (1993) 385-393
57. Senior R.M., Campbell E.J., Landis J.A., Cox F.R., Kuhn C., and Koren H.S. Elastase of U-937 monocytelike cells. Comparisons with elastases derived from human monocytes and neutrophils and murine macrophagelike cells. J. Clin. Invest. 69 (1982) 384-393
58. Senior R.M., and Campbell E.J. Cathepsin G in human mononuclear phagocytes: comparisons between monocytes and U937 monocyte-like cells. J. Immunol. 132 (1984) 2547-2551
59. Czapinska H., and Otlewski J. Structural and energetic determinants of the S1-site specificity in serine proteases. Eur. J. Biochem. 260 (1999) 571-595
60. Maison C.M., Villiers C.L., and Colomb M.G. Proteolysis of C3 on U937 cell plasma membranes. Purification of cathepsin G. J. Immunol. 147 (1991) 921-926
61. Tanaka T., Minematsu Y., Reilly C.F., Travis J., and Powers J.C. Human leukocyte cathepsin G. Subsite mapping with 4-nitroanilides, chemical modification, and effect of possible cofactors. Biochemistry 24 (1985) 2040-2047
62. Bank U., Kupper B., Reinhold D., Hoffmann T., and Ansorge S. Evidence for a crucial role of neutrophil-derived serine proteases in the inactivation of interleukin-6 at sites of inflammation. FEBS Lett. 461 (1999) 235-240
63. Hack L.W., Rostand K.S., Hunter F.A., and Bhown A. Isolation, characterization, and amino-terminal amino acid sequence analysis of human neutrophil cathepsin G from normal donors. Anal. Biochem. 158 (1986) 217-227
64. Hof P., Mayr I., Huber R., Korzus E., Potempa J., Travis J., Powers J.C., and Bode W. The 1.8 Å crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities. EMBO J. 15 (1996) 5481-5491
65. Sambrano G.R., Huang W., Farugi T., Mahrus S., Craik C., and Coughlin S.R. Cathepsin G activates protease-activated receptor-4 in human platelets. J. Biol. Chem. 275 (2000) 6819-6823
66. Turkington P.T., and Cathepsin G. a regulator of human vitamin K, dependent clotting factors and inhibitors. Thromb. Res. 67 (1992) 147-155
67. Owen C.A., and Campbell E.J. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition. J. Immunol. 160 (1998) 1436-1443
68. Chertov O., Ueda H., Xu L.L., Tani K., Murphy W.J., Wang J.M., Howard O.M., Sayers T.J., and Oppenheim J.J. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 186 (1997) 739-747
69. Newman S.L., Gootee L., Gabay J.E., and Selsted M.E. Identification of constituents of human neutrophil azurophil granules that mediate fungistasis against Histoplasma capsulatum. Infect. Immun. 68 (2000) 5668-5672
70. Sharfer W.M., Hubalek F., Huang M., and Pohl J. Bactericidal activity of a synthetic peptide (CG 117-136) of human lysosomal cathepsin G is dependent on arginine content. Infect. Immun. 64 (1996) 4842-4845
71. Travis J., Giles P.J., Porcelli L., Reilly C.F., Baugh R., and Powers J. Human leucocyte elastase and cathepsin G: structural and functional characteristics. Ciba Found. Symp. 75 (1979) 51-68
72. Heck L.W., Blackburn W.D., Irwin M.H., and Abrahamson D.R. Degradation of basement membrane laminin by human neutrophil elastase and cathepsin G. Am. J. Pathol. 136 (1990) 1267-1274
73. Capodici C., and Berg R.A. Cathepsin G degrades denatured collagen. Inflammation 13 (1989) 137-145
74. Baici A., Knopfel M., and Fehr K. Cleavage of the four human IgG subclasses with cathepsin G. Scand. J. Immunol. 16 (1982) 487-498
75. Baici A., Knopfel M., and Fehr K. Cathepsin G from human polymorphonuclear leukocytes cleaves human IgM. Mol. Immunol. 19 (1982) 719-727
76. Biggs J.R., Yang J., Gullberg U., Muchardt C., Yaniv M., and Kraft A.S. The human brm protein is cleaved during apoptosis: the role of cathepsin G. Proc. Natl. Acad. Sci. USA 98 (2001) 3814-3819
77. Berlov M.N., Lodygin P.A., Andreeva Y.V., and Kokryakov V.N. Isolation and some physical and chemical properties of elastase and cathepsin G from dog neutrophils. Biochemistry (Moscow) 66 (2001) 1008-1013
78. Friguet B., Szweda L.I., and Stadtman E.R. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch. Biochem. Biophys. 311 (1994) 168-173
79. Friguet B., and Szweda L.I. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett. 405 (1997) 21-25